Novel antibodies to erbB2 which inhibit the growth of tumor cell lines expressing varying levels of receptor

被引：0
|
作者：
Cartlidge, Susan
Dong, Jianying
Babcook, John
Kang, Jaspal
Foltz, Ian
Veldman-Jones, Margaret
Vincent, John
Blakey, David
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
[2] Abgenix Inc, Fremont, CA USA
[3] Amgen British Columbia, Burnaby, BC, Canada
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
831
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Transcriptome changes induced by docetaxel in human mammary cell lines expressing different levels of ERBB2
    Dos Santos, M. L.
    Gimenes, K. P.
    Silva, W. A., Jr.
    Nagai, M. A.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (06) : 733 - 743
  • [2] Differential effects of docetaxel on the expression profile of human mammary cell lines expressing different levels of ERBB2
    dos Santos, Mariana L.
    Gimenes, Karina R.
    Silva, Wilson A., Jr.
    Nagai, Maria A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3469S - 3469S
  • [3] MONOCLONAL-ANTIBODIES DIRECTED TO THE ERBB-2 RECEPTOR INHIBIT IN-VIVO TUMOR-CELL GROWTH
    HARWERTH, IM
    WELS, W
    SCHLEGEL, J
    MULLER, M
    HYNES, NE
    BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1140 - 1145
  • [4] MECHANISTIC ASPECTS OF THE OPPOSING EFFECTS OF MONOCLONAL-ANTIBODIES TO THE ERBB2 RECEPTOR ON TUMOR-GROWTH
    STANCOVSKI, I
    HURWITZ, E
    LEITNER, O
    ULLRICH, A
    YARDEN, Y
    SELA, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8691 - 8695
  • [5] Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression
    Dos Santos, Mariana Lopes
    Palanch, Carolina Goncalves
    Salaorni, Sibeli
    Da Silva, Wilson Araujo, Jr.
    Nagai, Maria Aparecida
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (06) : 1441 - 1461
  • [6] Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth
    Yang, L.
    Li, Y.
    Zhang, Y.
    CELL DEATH & DISEASE, 2014, 5 : e1211 - e1211
  • [7] Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth
    L Yang
    Y Li
    Y Zhang
    Cell Death & Disease, 2014, 5 : e1211 - e1211
  • [8] Androgen Receptor Controls EGFR and ERBB2 Gene Expression at Different Levels in Prostate Cancer Cell Lines
    Pignon, Jean-Christophe
    Koopmansch, Benjamin
    Nolens, Gregory
    Delacroix, Laurence
    Waltregny, David
    Winkler, Rosita
    CANCER RESEARCH, 2009, 69 (07) : 2941 - 2949
  • [9] Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
    Schoenfeld, Kurt
    Sahm, Christiane
    Zhang, Congcong
    Naundorf, Sonja
    Brendel, Christian
    Odendahl, Marcus
    Nowakowska, Paulina
    Boenig, Halyard
    Koehl, Ulrike
    Kloess, Stephan
    Koehler, Sylvia
    Holtgreve-Grez, Heidi
    Jauch, Anna
    Schmidt, Manfred
    Schubert, Ralf
    Kuehicke, Klaus
    Seifried, Erhard
    Klingemann, Hans G.
    Rieger, Michael A.
    Tonn, Torsten
    Grez, Manuel
    Wels, Winfried S.
    MOLECULAR THERAPY, 2015, 23 (02) : 330 - 338
  • [10] Evaluation of AZD8931, an Equipotent Inhibitor of erbB1, erbB2, and erbB3 Receptor Signaling, on Ligand Stimulated Breast Cancer Cell Lines with Differing Levels of erbB2 Expression
    Marshall, G.
    Klinowska, T. C. M.
    Mills, E. A.
    Ogilvie, D.
    Hickinson, D. M.
    Speake, G.
    CANCER RESEARCH, 2009, 69 (24) : 784S - 785S
12345